Take Homes from AACR-NCI-EORTC

In this video, Lillian L. Siu, MD, FRCPC, discussed a panel discussion at 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics on the topic of in drug development roadblocks.

In this video, Lillian L. Siu, MD, FRCPC, senior medical oncologist at Princess Margaret Cancer Centre in Toronto, ON, Canada, discussed presentations on new drugs on the horizon, including mutant-specific inhibitors and FGFR2-inhibitors.

In this video, Lillian L. Siu, MD, FRCPC, discusses two keynote presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

In this video, Stan Lipkowitz, MD, PhD, chief of the women's malignancies branch in the National Cancer Institute's Center for Cancer Research, discusses new research into targeting protein degradation.

In this video, Stan Lipkowitz, MD, PhD, chief of the women's malignancies branch in the National Cancer Institute's Center for Cancer Research, discusses a session on the development of HER2 targeted therapies for breast cancer at AACR-NCI-EORTC.

In this video, Stan Lipkowitz, MD, PhD, chief of the women's malignancies branch in the National Cancer Institute's Center for Cancer Research, discusses the keynote talk on CRISPR presented at AACR-NCI-EORTC.

In this video, Pasi Jänne, MD, PhD, professor of medicine, Harvard Medical School, discussed studies looking at combining therapies with sotorasib. Those combinations included sotorasib and trametinib for KRAS p.G12C-mutated solid tumors and sotorasib and afatinib for KRAS p.G12C mutated non-small cell lung cancer.

In this video, Pasi Jänne, MD, PhD, Professor of Medicine, Harvard Medical School, discusses a session on KRAS mutant lung cancers presented at AACR-NCI-EORTC. In the session, new KRAS inhibitors that bind to the novel mutations were discussed.